Timber Pharmaceuticals, Inc.
(NYSE Amex Equities : TMBR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -1.43%162.860.7%$1035.04m
MRKMerck & Co., Inc. -0.68%76.710.7%$980.93m
LLYEli Lilly & Co. -1.04%219.891.1%$902.80m
PFEPfizer Inc. -1.29%38.970.9%$889.55m
ABBVAbbVie, Inc. -1.15%113.581.9%$724.81m
BMYBristol-Myers Squibb Co. -0.38%66.521.0%$620.13m
AZNAstraZeneca Plc -0.94%57.801.2%$393.83m
ANVSAnnovis Bio, Inc. 4.53%94.130.0%$320.29m
OGN -3.74%30.290.0%$316.03m
NVSNovartis AG -1.11%93.110.2%$179.85m
GSKGlaxoSmithKline Plc -1.76%39.860.2%$149.55m
NOVNNovan, Inc. 0.10%10.865.8%$140.02m
ORPHOrphazyme A/S -45.64%7.910.0%$128.45m
BTXBrooklyn ImmunoTherapeutics, Inc. 10.27%16.9212.4%$104.76m
CNSTConstellation Pharmaceuticals, Inc. -0.15%33.770.0%$104.68m

Company Profile

Timber Pharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development and commercialization of treatments for orphan dermatologic diseases. Its initial focus on developing non-systemic treatments for rare dermatologic diseases, including congenital ichthyosis, tuberous sclerosis complex, and localized scleroderma. The company was founded in 2019 and is headquartered in Basking Ridge, NJ.